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Protein misfolding diseases include highly 
debilitating degenerative disorders like 
Alzheimer’s and Parkinson’s diseases [1]. The 
healthcare and financial burden linked to 
these pathologies has been steadily increas-
ing over the past decade [2]. Actually, there is 
currently no efficient treatment for misfold-
ing diseases as well as no reliable early diag-
nostic techniques for them [3]. It is known 
that, in many cases, the cytotoxic effect of 
misfolded proteins is exerted through their 
self-assembly into amyloid-like protein 
aggregates [4]. Unfortunately, the mecha-
nisms responsible for the toxicity of protein 
aggregates are still not completely under-
stood. The number of protein targets whose 
misfolding and aggregation is being shown 
to be associated with the onset of pathologic 
conditions is constantly increasing [5]. Since 
the development of degenerative disorders 
is expected to increase at a similar rate than 
life expectancy, it is likely that in the years 
to come misfolding diseases would become 
more common and prevalent than previ-
ously thought. We should be prepared to 
deal with such a dramatic scenario and join 
research efforts to understand the molecular 
mechanism that underlies these devastating 
disorders without further delay.
In this issue, we highlight recent advances 
in the study of protein misfolding disor-
ders and their protein targets, but it is also 
described how different organisms exploit 
the amyloid fold for the functional and 
dynamic assembly of biological structures, 
in a review by S Fabio Falsone [6]. The 
complexity of misfolding diseases makes 
indispensable the use of different model 
organisms to model these pathologies; 
Kevin A Morano and coworkers describe 
how these models have been used for phar-
macological and molecular modeling or 
cognitive assessment [7]. In all these models, 
as well as in humans, protein misfolding is 
antagonized by the heat shock response and 
the unfolded protein response, which are the 
major stress response pathways within pro-
tein quality control. Martin L Duennwald 
illustrates how cooperation between these 
different stress response pathways might play 
an important role in defining protein toxicity 
in Huntington’s and other brain disorders [8]. 
In fact, the devastating CNS glioblastomas 
exploits the unfolded protein response to 
allow their continued uncontrolled growth, 
becoming thus a potential target for treat-
ment intervention, as reviewed by Michael 
Graner [9]. Spinal and bulbar muscular atro-
phy, is a neuromuscular degenerative disease 
that, as in the case of the better characterized 
Huntignton’s disease, arises from expansion 
of the polyglutamine repeats, in this case in 
the androgen receptor, indicating that simi-
lar sequential changes might lead to different 
disorders depending on the protein target in 
which they occur, as reported by Folake A 
Orafidiya and Iain J McEwan [10]. In fact, 
the propensity of a protein to form amyloid 
assemblies is imprinted in its sequence and 
can be read using computational approaches. 
An analysis of the aggregation propensity 
of neuroreceptors by Salvador Ventura and 
coworkers highlights the overlap between 
aggregation-prone regions and receptors 
“The number of protein targets whose misfolding and aggregation  
is being shown to be associated with the onset of pathologic conditions 
 is constantly increasing.”
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interfaces and/or ligand-binding sites suggesting that 
anomalous interactions between them and protein 
aggregates might cause wrong signaling in brain neu-
rones [11]. Cystic fibrosis is an inherited, misfolding 
disease impacting respiratory function. This disorder 
illustrates how the knowledge about the genetic and 
protein causes for misfolding diseases might lead to 
effective therapies that improve patient’s life expec-
tancy, as detailed in the review by Deborah O’Neil 
and Douglas Fraser-Pitt [12]. The increasing impact 
that misfolding diseases might have in our society is 
exemplified in the last article of this issue by Xavier 
Fernandez-Busquets and coworkers, where they discuss 
evidences supporting the role of amyloid assemblies in 
the pathobiology of malaria. The amyloid structures 
of the plasmodium parasite may become attractive tar-
gets to fight against this devastating disease [13]. This 
issue therefore brings together updated information 
on the causes underlying misfolding diseases, outlines 
the different pathways that might be taken in the next 
future for therapeutic intervention and provide fresh 
and provoking ideas on the role of amyloids in health 
and disease.
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